Academic Journals & Publications
Showcasing New-Line Biotech's rigorous academic contributions in bacteriophage genomics, novel endolysins (e.g. Lys81 against MRSA), farm-level clinical trials, and non-antibiotic animal health management.
Academic Journal 2026-09-04 New-Line Bio Co-Authors in Frontiers in Microbiology: Unveiling Novel Endolysin Lys81 Against Clinical Methicillin-Resistant Staphylococcus aureus (MRSA)
In collaboration with clinical medical centers and Nanjing Agricultural University, New-Line Bio co-published breakthrough research in Frontiers in Microbiology on prophage mining in clinical MRSA strains and the discovery of novel endolysin Lys81, demonstrating potent lytic efficacy across multidrug-resistant staphylococcal biofilms.
Academic Journal 2026-08-28 Will Long-Term Phage Drinking Water Administration Induce Bacterial "Phage Resistance"? Scientific Evidence and Strategic Countermeasures
A primary concern among livestock producers transitioning from antibiotics is whether chronic phage exposure mimics antibiotic resistance. Evolutionary biology demonstrates that bacterial phage-resistance mutations carry severe fitness costs (attenuated virulence, restored antibiotic sensitivity). Furthermore, New-Line Bio’s multi-receptor cocktail design continuously circumvents resistance mechanisms.
Academic Journal 2026-08-14 White-Feather Broilers Face the High-Profitability Challenge: How Phage Aerosol Spraying Drops Environmental E. coli Loads by Log Orders
With broiler margins opening up, managing seasonal respiratory and systemic colibacillosis is decisive. New-Line Bio’s automated phage fine aerosol spray protocol in poultry houses directly reduces airborne and surface pathogenic E. coli loads by multiple log orders, slashing early-stage mortality and airsacculitis.
Academic Journal 2026-08-07 Aquaculture Under Regulatory Scrutiny: The True Hazards of Bullfrog Antibiotic Residues and the Phage Biocontrol Solution
Severe enrofloxacin and florfenicol residue exceedances in commercial bullfrog farming have triggered massive market penalties. New-Line Bio’s targeted aquatic phage cocktail clears Aeromonas hydrophila and Edwardsiella in water and intestinal tracts, achieving complete antibiotic substitution without withdrawal delays.
Academic Journal 2026-07-24 The Critical First 72 Hours: Equipping Day-Old Chicks with an "Invisible Armor" Through Targeted Bacteriophage Biosecurity
Immature gut immunity makes neonate chicks exceptionally susceptible to perinatal colibacillosis and omphalitis. Supplying specific lytic bacteriophages in early drinking water equips chicks with rapid biological barriers that outcompete pathogens during the critical 72-hour window.
Academic Journal 2026-07-17 Overcoming the Intracellular Parasitism Dilemma: Core Mechanisms of Bacteriophage Biocontrol Against Avian Salmonella Pullorum
Salmonella Pullorum evades conventional antibiotics through intracellular persistence in macrophages and systemic vertical transmission. New-Line Bio’s virulent phage cocktail intercepts pathogens prior to mucosal translocation, disrupting colonization cascades and providing breeder flocks with effective negative-status maintenance.
Academic Journal 2026-07-10 Overcoming Immunosuppression: How Bacteriophage Therapy Modulates Teleost Fish IgM Antibody Titers and Mucosal Immunity
Conventional aquatic antibiotic treatments often trigger severe immunosuppression in aquatic animals, creating vulnerability to secondary opportunistic infections. Research confirms that precision phage therapy eliminates pathogens while sparing gut microbiota, actively upregulating serum and mucosal IgM antibody titers to bolster systemic defense.
Academic Journal 2026-07-03 The Heavy Price of "Instant Cures": Examining Imipenem Abuse in Veterinary Clinics and the Phage Biocontrol Alternative
In pet clinics, the pursuit of rapid clinical responses has led to growing reliance on carbapenems like imipenem—the last line of human medical defense. This abuse accelerates carbapenem-resistant Enterobacteriaceae (CRE) emergence. New-Line Bio highlights precision lytic bacteriophages as sustainable, residue-free alternatives that protect both animal welfare and public health.
Academic Journal 2026-06-26 Under the Global Veterinary Antimicrobial Reduction Trend: Why WOAH and International Bodies Urge Global Adoption of Bacteriophages
Amid worldwide regulatory bans on growth-promoting antibiotics, livestock and aquaculture face intense superbug pressure. The World Organisation for Animal Health (WOAH), FAO, and WHO increasingly champion bacteriophages as prime targeted non-antibiotic alternatives that eliminate pathogenic bacteria without triggering collateral antimicrobial resistance.
Academic Journal 2026-06-19 Seafood Exports Facing "Antibiotic Residue Barriers"? How Bacteriophages Help Asia-Pacific Aquaculture Producers Overcome Trade Hurdles
Export aquaculture operators—from white shrimp to tilapia and eel—face increasingly stringent international testing standards with near-zero tolerance for drug residues. New-Line Bio’s marine phage cocktails provide targeted Vibrio and Aeromonas clearance, ensuring safe export compliance and superior harvest survival.
Academic Journal 2026-06-12 National Media Highlights "Antibiotic Residue Excess": Why the Food Industry Urgently Demands a Comprehensive Antibiotic-Free Bio-Solution
Repeated national food inspection bulletins highlighting veterinary antibiotic residues in eggs, poultry, and aquaculture have shaken consumer trust. Green bio-solutions utilizing virulent bacteriophages provide agricultural enterprises with zero-withdrawal, residue-free biological barriers from breeding to slaughter.
Academic Journal 2026-05-15 Synergistic Partnership: Mechanisms of Bacteriophage and Bacillus subtilis Co-Action in Broiler Feed Growth Promotion
Combining host-specific lytic phages with probiotic Bacillus subtilis creates powerful symbiotic synergy: while bacteriophages swiftly decimate enteric pathogen loads (Salmonella, E. coli, Clostridium), Bacillus subtilis rapidly colonizes mucosal niches, secretes digestive enzymes, and accelerates epithelial villus regeneration to optimize feed conversion.
Academic Journal 2026-04-30 A Stealth Threat Across Animal Husbandry and Food Safety: New-Line Bio Deploys Precision Bacteriophage Formulations Against Staphylococcus aureus
Staphylococcus aureus causes pervasive subclinical mastitis in dairy herds, bumblefoot and gangrenous dermatitis in poultry, and enterotoxin food poisoning. New-Line Bio’s lytic phage and endolysin pipeline offers selective biocontrol that eradicates resistant biofilms across production chains.
Academic Journal 2026-03-13 Can Phages Modulate Mood Disorders? Unveiling Micro-Therapies in Microbiota-Gut-Brain Axis Science
Cutting-edge research published in Cell Host & Microbe reveals that bacteriophages in the human gut microbiome act as upstream orchestrators of gut-brain axis signaling. By selectively pruning inflammatory bacteria that disrupt tryptophan and serotonin metabolism, phages represent a revolutionary frontier in psychomicrobiology and metabolic health.
Academic Journal 2026-02-27 Inspiration from AI Breakthroughs: How Artificial Intelligence Empowers High-Throughput Bacteriophage Discovery and Bioengineering
As AI evolves from scientific novelty into ubiquitous infrastructure, modern phage biology is undergoing a profound paradigm shift. New-Line Bio integrates machine learning with our "Three Libraries, One Platform" architecture, leveraging generative models and protein structural prediction to accelerate lytic enzyme discovery, receptor binding protein (RBP) optimization, and broad-host-range cocktail engineering.
Scientific Column 2026-01-23 Global Milestone! EU Officially Approves Bacteriophage Feed Additive, Ushering in a Green Era
The European Commission's landmark authorization of bacteriophage preparations as zootechnical feed additives represents a monumental international regulatory breakthrough, confirming global acceptance of phage bio-solutions.
Scientific Column 2022-07-06 Clinical Case | The Bio-Savior Against Multi-Drug Resistant Superbugs!
As natural biological agents capable of precise bacterial eradication without generating resistance, bacteriophages deliver revolutionary breakthroughs for refractory clinical bacterial infections and antibiotic-free green farming.
Scientific Column 2022-06-29 Technical Application | Practical Utilization of Bacteriophage Formulations in Aquaculture
Exploring the application mechanisms and practical benefits of precision bacteriophage preparations in water quality stabilization, pathogenic Vibrio control, and antibiotic-free aquaculture health management.
Scientific Column 2022-03-18 Science Topic | Bacteriophages: Opening New Frontiers in Antimicrobial Research
With escalating antimicrobial resistance, bacteriophage therapy has re-emerged as a major global scientific frontier, providing safe and effective bio-solutions for animal husbandry, medicine, and food safety.
Scientific Column 2022-03-07 Science Topic | Nature's Precision Bacterial Hunter: Bacteriophages
Bacteriophages are viruses that specifically target and lyse bacteria. As natural bacterial predators, they offer targeted bacterial control without disturbing beneficial microflora or inducing drug resistance.
No articles match your search criteria.